Ultragenyx Pharmaceutical Inc., Director at Arcturus Therapeutics Holdings Inc. (ARCT), sold 800,000 shares at $45.83 ($43.6M) on 2021-08-11, disclosed to the SEC on 2021-08-12.
Open-market sale of $43.6M ARCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.44 | 725,000 | $40.2M | 92.1% |
| 2 | $45.83 | 75,000 | $3.4M | 7.9% |
| Total | $54.54 avg | 800,000 | $43.6M | 100% |